๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 36 Shanghai 14 Chongqing 12 Nanjing 6 Chengdu 6
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking University3 Eli Lilly and Company3 Jing Liu3 China National Center for Cardiovascular Diseases3 Beijing Friendship Hospital3
Site location
Beijing36 Shanghai14 Chongqing12 Nanjing6 Chengdu6
All 60 locations
Target enrolment
to

Trials with a site in Beijing

36 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Songling Xuemaikang in Hypertension and Insomnia Evaluation๏ผˆSHINE๏ผ‰
NCT07709442Hypertension
DrugSongling Xuemaikang
Jing Liu
Not applicable
260
Beijing
2026-06-30
Recruiting
Salt Sensitivity Evaluation Via N-of-1 Trials (SENSE-Salt)
NCT07614724Salt-Sensitivity of Blood Pressure, Hypertension
Peking University
Not applicable
72
Beijing
2026-06-02
Not yet open
Study of IBI3016 in People With Mild or Moderate Hypertension Patients
NCT07556796Hypertension
DrugIBI3016
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
30
Beijing
2026-05-15
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
NCT07607275Hypertension, Essential (Primary) Hypertension
Beijing Anzhen Hospital
Phase 4
350
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing
2026-05-15
Recruiting
A Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District
NCT07804420Hypertension
Peking University
Not applicable
500
Beijing
2026-04-01
Not yet open
Chronic Kidney Disease and Metabolic Disorders in the Elderly
NCT07494526Chronic Kidney Diease, Diabetes Mellitus, Hypertension, Hyperlipidemia
Chinese PLA General Hospital
Observational
100,000
Beijing
2026-04
Active, closed
A Study of VCT220 in Participants With Hypertension and Obesity or Overweight
NCT07360275Hypertension
DrugCX11
Vincentage Pharma Co., Ltd
Phase 2
160
Beijing
2026-03-01
Not yet open
A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients
NCT07352969Hypertension
DrugIBI3016
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
352
Beijing
2026-02-06
Not yet open
Songling Xuemaikang Capsules for Cerebral Small Vessel Disease
NCT07271732Hypertension, Cerebral Small Vessel Diseases
DrugSongling Xuemaikang
Dongzhimen Hospital, Beijing
Not applicable
90
Beijing
2025-12-10
Not yet open
Efficacy and Safety Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Regulation
NCT07239492Hypertension, Hypotension
Xuanwu Hospital, Beijing
Not applicable
25
Beijing
2025-12-01
Not yet open
Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity
NCT07241338Hypertension
DrugAmlodipine
Jing Liu
Phase 4
104
Beijing
2025-11
Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk
DrugZilebesiran
Alnylam Pharmaceuticals
Phase 3
11,000
Beijing, Binhai, Changchun, Changsha, Chengdu, Chongqing, Dalian, Datong
2025-09-22
By invitation
A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease
NCT07130955Hypertension, CKD - Chronic Kidney Disease
Shanghai Golden Leaf MedTec Co. Ltd
Not applicable
236
Beijing
2025-08-08
By invitation
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDN
NCT07273877Hypertension
Shanghai Golden Leaf MedTec Co. Ltd
Observational
1,000
Beijing
2025-08-07
Recruiting
EASi-PROTKTโ„ข - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
DrugsVicadrostat·Empagliflozin
Boehringer Ingelheim
Phase 3
11,800
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dalian
2025-07-22
Recruiting
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
NCT07400549Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia
China National Center for Cardiovascular Diseases
Not applicable
100
Beijing
2025-06-01
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
NCT06948435Hypertension, Overweight or Obesity
DrugOrforglipron
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
NCT06952530Hypertension
DrugOrforglipron
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
NCT06948422Hypertension
DrugOrforglipron
Eli Lilly and Company
Phase 3
974
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Not yet open
SMART Study in Real World
NCT06780696Hypertension, Uncontrolled Hypertension, Resistant Hypertension, Reduce Antihypertensive Drug Burden
SyMap Medical (Suzhou), Ltd.
Observational
1,000
Beijing
2025-02
Not yet open
Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
NCT06760078Spontaneous Intracranial Hemorrhage, Hypertension
DrugTranexamic acid (TXA)
Xuanwu Hospital, Beijing
Phase 4
532
Beijing
2024-12-31
By invitation
Adaptive Cognitive Training on Cognitive Function in Elderly Hypertension Patients in the Community
NCT06512922Hypertension, Condition, Aging
Peking University
Not applicable
120
Beijing
2024-10-29
Recruiting
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
NCT04974138Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcyโ‰ฅ10ยตmol/L), Insufficient Plasma Folate Levels (<12ng/mL)
DrugsAmlodipine besylate·Amlodipine besylate and folic acid·Amlodipine
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4
32,000
Bengbu, Bozhou, Chizhou, Fuyang, Beijing, Yangjiang, Guiyang, Huaihua
2024-08-22
Recruiting
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
NCT04974151Hypertension, MTHFR 677 TT Genotype
DrugsAmlodipine besylate·Amlodipine besylate and folic acid·Amlodipine
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4
24,000
Bengbu, Bozhou, Chizhou, Fuyang, Beijing, Yangjiang, Guiyang, Huaihua
2024-08-22
Recruiting
Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study
NCT07149688Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD), Heart Failure
Beijing Anzhen Hospital
Observational
30,000
Beijing
2024-03-01
Recruiting
Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
NCT06055452Pre-Heart Failure, Hypertension
DrugsJardiance·Empagliflozin
China National Center for Cardiovascular Diseases
Phase 4
120
Beijing, Shenzhen
2024-01-19
Not yet open
Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension
NCT05416840Hypertension
DrugAmlodipine
Jing Liu
Phase 4
92
Beijing
2024-01
Active, closed
Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
NCT05749874PreDiabetes, Abdominal Obesity, Hypertension, Dyslipidemias
DrugBerberine
China National Center for Cardiovascular Diseases
Phase 4
2,024
Beijing
2023-10-31
Recruiting
Clinical Indicators and Brain Image Data: a Study Based on Kailuan Cohort
NCT05453877Brain Diseases, Hypertension
Beijing Friendship Hospital
Observational
1,000
Beijing, Tangshan
2022-08-01
Recruiting
Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases
NCT05476627Chronic Kidney Diseases, Hypertension, Diabetes Mellitus, Hyperuricemia
Peking Union Medical College Hospital
Observational
200
Beijing
2022-07-01
Recruiting
Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
NCT05644548Hypertension, Diabetes Mellitus, Dyslipidemias
Beijing Tongren Hospital
Observational
300
Beijing
2022-03-01
Recruiting
Integrated Diagnosis and Treatment of CKD on Outcomes
NCT05242055Chronic Kidney Diseases, Hypertension, Hyperglycemia, Hyperlipidemias
Capital Medical University
Observational
1,000
Beijing
2022-02-01
Recruiting
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
NCT05498675Sacubitril/Valsartan, Hypertension, Obesity
DrugsSacubitril/valsartan·ACEI/ARB
Beijing Friendship Hospital
Observational
180
Beijing
2021-09-01
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Beijing, Guangzhou, Changsha, Shanghai
2019-09-23
Recruiting
Effect of Bariatric Surgery on Cardiac Function in Patients With Hypertension
NCT05166954Bariatric Surgery, Hypertension
Beijing Friendship Hospital
Observational
40
Beijing
2018-08-01
Active, closed
Sympathetic Mapping/ Ablation of Renal Nerves Trial
NCT02761811Hypertension
SyMap Medical (Suzhou), Ltd.
Not applicable
220
Beijing, Chongqing, Shenzhen, Shijiazhuang, Daqing, Wuhan, Nanjing, Xuzhou
2016-06-30
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

16 of the 36 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 10 have not yet opened recruitment, 6 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 36 studies
PhaseStudiesRecruitingShare
Observational10727.8%
Not applicable9325%
Phase 48422.2%
Phase 36216.7%
Phase 2205.6%
Phase 1102.8%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Beijing Friendship Hospital33
China National Center for Cardiovascular Diseases32
Eli Lilly and Company30
Jing Liu30
Peking University32
Beijing Anzhen Hospital22
Innovent Biologics (Suzhou) Co. Ltd.20
Shanghai Golden Leaf MedTec Co. Ltd20
Shenzhen Ausa Pharmed Co.,Ltd22
SyMap Medical (Suzhou), Ltd.20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.